Show simple item record

dc.contributorUniversitat Ramon Llull. IQS
dc.contributor.authorBalcells, Mercedes
dc.contributor.authorClaeyssens, Frederik
dc.contributor.authorDikici, Serkan
dc.contributor.authorDikici, Betül Aldemir
dc.contributor.authorBhaloo, Shirin Issa
dc.contributor.authorEdelman, Elazer R.
dc.contributor.authorMacNeil, Sheila
dc.contributor.authorReilly, Gwendolen C.
dc.contributor.authorSherborne, Colin
dc.date.accessioned2021-06-10T06:46:59Z
dc.date.accessioned2023-07-13T05:46:08Z
dc.date.available2021-06-10T06:46:59Z
dc.date.available2023-07-13T05:46:08Z
dc.date.issued2020-01
dc.identifier.urihttp://hdl.handle.net/20.500.14342/1123
dc.description.abstractAngiogenesis is a highly ordered physiological process regulated by the interaction of endothelial cells with an extensive variety of growth factors, extracellular matrix components and mechanical stimuli. One of the most important challenges in tissue engineering is the rapid neovascularization of constructs to ensure their survival after transplantation. To achieve this, the use of pro-angiogenic agents is a widely accepted approach. The study of angiogenesis has gained momentum over the last two decades. Although there are various in vitro, ex vivo, and in vivo angiogenesis models that enable testing of newly discovered pro-angiogenic agents, the problem with researching angiogenesis is the choice of the most appropriate assay. In vivo assays are the most representative and reliable models, but they are expensive, time-consuming and can cause ethical concerns whereas in vitro assays are relatively inexpensive, practical, and reproducible, but they are usually lack of enabling the study of more than one aspect of angiogenesis, and they do not fully represent the complexity of physiological angiogenesis. Therefore, there is a need for the development of an angiogenesis model that allows the study of angiogenesis under physiologically more relevant, dynamic conditions without causing ethical concerns. Accordingly, in this study, we developed 3D in vitro dynamic angiogenesis model, and we tested the angiogenic potential of 2-deoxy-D-ribose (2dDR) in comparison with vascular endothelial growth factor (VEGF) using newly developed in vitro 3D dynamic model and well-established in vitro models. Our results obtained using conventional in vitro assays demonstrated that 2dDR promoted proliferation, migration and tube formation of human aortic endothelial cells (HAECs) in a dose-dependent manner. Then, the angiogenic activity of 2dDR was further assessed using the newly developed 3D in vitro model, which enabled the monitoring of cell proliferation and infiltration simultaneously under dynamic conditions. Our results showed that the administration of 2dDR and VEGF significantly enhanced the outgrowth of HAECs and the cellular density under either static or dynamic conditions.eng
dc.format.extent20 p.cat
dc.language.isoengcat
dc.publisherFrontiers Mediacat
dc.relation.ispartofFrontiers in Bioengineering and Biotechnology. Vol.7 (2020), 451cat
dc.rightsAttribution 4.0 International
dc.rights© L'autor/a
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceRECERCAT (Dipòsit de la Recerca de Catalunya)
dc.subject.otherEndoteli vascularcat
dc.subject.otherAngiogenesiscat
dc.subject.otherVascular endothelial growth factor (VEGF)cat
dc.subject.other2-deoxy-D-ribose (2dDR)cat
dc.subject.otherThymidine phosphorylase (TP)cat
dc.subject.otherAngiogenesis assayscat
dc.subject.otherShear stresscat
dc.subject.otherEmulsion templatingcat
dc.subject.otherPolyHIPEcat
dc.titleAssessment of the angiogenic potential of 2-deoxy-D-ribose using a novel in vitro 3D dynamic model in comparison with established in vitro assayscat
dc.typeinfo:eu-repo/semantics/articlecat
dc.typeinfo:eu-repo/semantics/publishedVersioncat
dc.rights.accessLevelinfo:eu-repo/semantics/openAccess
dc.embargo.termscapcat
dc.subject.udc57
dc.identifier.doihttps://doi.org/10.3389/fbioe.2019.00451cat
dc.relation.projectID​info:eu-repo/grantAgreement/EPSRC/EP/I007695/1cat
dc.relation.projectID​info:eu-repo/grantAgreement/MRC/MR/L012669/1cat
dc.relation.projectIDinfo:eu-repo/grantAgreement/MINECO/PN I+D/SAF2017-84773-C2-1-Rcat
dc.relation.projectIDinfo:eu-repo/grantAgreement/US National Institute of Health/R01 49039cat


Files in this item

 

This item appears in the following Collection(s)

Show simple item record

Attribution 4.0 International
Except where otherwise noted, this item's license is described as http://creativecommons.org/licenses/by/4.0/
Share on TwitterShare on LinkedinShare on FacebookShare on TelegramShare on WhatsappPrint